1-12 of 12
Hans-Georg Rammensee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma

Henning Zelba, Jens Bedke, Jörg Hennenlotter, Sven Mostböck, Markus Zettl, Thomas Zichner, Anoop Chandran, Arnulf Stenzl, Hans-Georg Rammensee, Cécile Gouttefangeas
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (11): 1891–1899.
https://doi.org/10.1158/2326-6066.CIR-19-0146
Published: 01 November 2019
View article titled, PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma
Open the PDF for PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma

Alexander Ulges, Norbert Hilf, Wolfgang Wick, Michael Platten, Pierre-Yves Dietrich, Katrin Frenzel, Arie Admon, Sjoerd S.H. van der Burg, Andreas von Deimling, Per thor Straten, Cecile Gouttefangeas, Judith R. Kroep, Francisco Martínez-Ricarte, Hideo Okada, Christian H. Ottensmeier, Berta Ponsati, Hans S. Poulsen, Stefan Stevanovic, Ghazaleh Tabatabai, Hans-Georg Rammensee, Ugur Sahin, Dominik Maurer, Regina Mendrzyk
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): A020.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A020
Published: 01 February 2019
View article titled, Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma
Journal Articles

Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients

Armin Rabsteyn, Christina Kyzirakos, Christopher Schroeder, Marc Sturm, Christopher Mohr, Jakob Matthes, Magdalena Feldhahn, Nicolas Casadei, Martin Ebinger, Stefan Stevanovic, Peter Bauer, Oliver Kohlbacher, Cecile Gouttefangeas, Juergen Schaefer, Hans-Georg Rammensee, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): B124.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-B124
Published: 01 February 2019
View article titled, Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients
Journal Articles

Abstract A043: Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant®): HEPAVAC

Andrea Mayer-Mokler, Roberto Accolla, Yuk T. Ma, Regina Heidenreich, Francesco Izzo, Alfred Koenigsrainer, Markus Loeffler, Christian Flohr, Phillip Mueller, Sarah Kutscher, Hans-Georg Rammensee, Bruno Sangro, Sven Francque, Danila Valmori, Toni Weinschenk, Carsten Reinhardt, Ulrike Gnad-Vogt, Harpreet Singh, Luigi Buonaguro
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): A043.
https://doi.org/10.1158/2326-6066.IMM2016-A043
Published: 31 October 2016
View article titled, Abstract A043: Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant®): HEPAVAC
Journal Articles

Abstract B057: Optimizing the high throughput in vitro priming of tumor specific T cells

Lea Prokop, Stefanie Souczek, Janet Peper, Hans-Georg Rammensee, Stefan Stevanović
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B057.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B057
Published: 03 January 2016
View article titled, Abstract B057: Optimizing the high throughput in vitro priming of tumor specific T cells
Journal Articles

Abstract A115: Cancer vaccine development for hepatocellular carcinoma – HEPAVAC

Luigi Buonaguro, Sarah Kutscher, Roberto Accolla, Yuk T. Ma, Regina Heidenreich, Francesco Izzo, Alfred Koenigsrainer, Markus Loeffler, Phillip Mueller, Andrea Mayer, Hans-Georg Rammensee, Bruno Sangro, Sven Francque, Danila Valmori, Toni Weinschenk, Harpreet Singh-Jasuja
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A115.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A115
Published: 03 January 2016
View article titled, Abstract A115: Cancer vaccine development for hepatocellular carcinoma – HEPAVAC
Journal Articles

Abstract A170: The mode of action of Orf virus – a novel viral vector for therapeutic cancer vaccines

Melanie Mueller, Ralf Amann, Thomas Feger, Hans-Georg Rammensee
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A170.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A170
Published: 03 January 2016
View article titled, Abstract A170: The mode of action of Orf virus – a novel viral vector for therapeutic cancer vaccines
Journal Articles

Abstract A112: Mapping the impact of proteasome inhibitor therapy on the antigenic landscape of multiple myeloma: Identifying robust targets for T cell immunotherapy

Daniel J. Kowalewski, Simon Walz, Linus Backert, Heiko Schuster, Oliver Kohlbacher, Lothar Kanz, Helmut R. Salih, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Stickel
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A112.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A112
Published: 03 January 2016
View article titled, Abstract A112: Mapping the impact of proteasome inhibitor therapy on the antigenic landscape of multiple myeloma: Identifying robust targets for T cell immunotherapy
Journal Articles

Abstract B104: Characterization and specificity analysis of tumor infiltrating lymphocytes in ovarian carcinoma

Janet Kerstin Peper, Kevin Röhle, Heiko Schuster, Philipp Wagner, Hans-Georg Rammensee, Stefan Stevanovic
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B104.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B104
Published: 03 January 2016
View article titled, Abstract B104: Characterization and specificity analysis of tumor infiltrating lymphocytes in ovarian carcinoma
Journal Articles

Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants

Armin Rabsteyn, Christina Kyzirakos, Christopher Schröder, Marc Sturm, Christopher Mohr, Mathias Walzer, Ulrike Pflückhahn, Michael Walter, Magdalena Feldhahn, Karoline Laske, Michael Bonin, Martin Ebinger, Stefan Stevanovic, Peter Bauer, Oliver Kohlbacher, Cecile Gouttefangeas, Hans-Georg Rammensee, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A113.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A113
Published: 03 January 2016
View article titled, Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants
Journal Articles

Abstract B144: Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody

Ursula Joerdis Eva Seidel, Ludger Grosse-Hovest, Patrick Schlegel, Martin Hofmann, Friedhelm R. Schuster, Roland Meisel, Kai-Erik Witte, Steffen Aulwurm, Elwira Pyz, Hans-Georg Rammensee, Gundram Jung, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B144.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B144
Published: 03 January 2016
View article titled, Abstract B144: Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody
Journal Articles

Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity

Karoline Laske, Yuriy V. Shebzukhov, Ludger Grosse-Hovest, Dmitry V. Kuprash, Svetlana V. Khlgatian, Ekaterina P. Koroleva, Alexey Y. Sazykin, Dmitry N. Penkov, Pavel V. Belousov, Stefan Stevanović, Verona Vass, Steffen Walter, David Eisel, Barbara D. Schmid-Horch, Sergei A. Nedospasov, Hans-Georg Rammensee, Cécile Gouttefangeas
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (3): 190–200.
https://doi.org/10.1158/2326-6066.CIR-13-0079
Published: 08 September 2013
View article titled, Alternative Variants of Human <em>HYDIN</em> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity
Open the PDF for Alternative Variants of Human <em>HYDIN</em> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity in another window
Includes: Supplementary data